kresmion.
Pull a receipt

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.37
As of

Kresmion compiles this page from RVPH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-12.

As of . Source: SEC EDGAR filings for RVPH. Method and limitations.

COMPANY DOSSIER

See the full RVPH dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for RVPH on one page. Preview it with sample data, then open it live with a free account.

Preview the RVPH dossier

Active events for RVPH

  • mediumEarnings above estimates

    Q1-2025: Beat consensus by 30.2% - EPS $-2.6 vs $-3.723 estimate

    All 2026-06-20 events →
  • mediumEarnings below estimates

    Q2-2025: Missed consensus by 7.0% - EPS $-2.4 vs $-2.244 estimate

    All 2026-06-20 events →
  • mediumEarnings above estimates

    Beat consensus by 30.2% - EPS $-2.6 vs $-3.723 estimate

    All 2026-06-05 events →
  • mediumEarnings below estimates

    Missed consensus by 7.0% - EPS $-2.4 vs $-2.244 estimate

    All 2026-06-05 events →
  • mediumEarnings above estimates

    Q3-2025: Beat consensus by 39.4% - EPS $-1.2 vs $-1.9817 estimate

    All 2026-06-05 events →

FREE, NO ACCOUNT

Every event on RVPH, as it fires

You are seeing 5 of 6 events recorded on RVPH since 2026-06-05.

The five above landed across 2 days. The other 1 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, RVPH

Going concern statement

RVPH's 10-Q filed Aug 12, 2026 states:

These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year after the date the consolidated financial statements are issued.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on RVPH

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in RVPH on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on RVPH in the last 180 days.

Upstream: SEC EDGAR filings for RVPH

Kresmion, "REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) institutional holdings and SEC filings", data as of 2026-08-12, https://kresmion.com/research/RVPH. Upstream data: SEC EDGAR filings for RVPH.

Link to this data (HTML):

<a href="https://kresmion.com/research/RVPH">REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow RVPH on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to RVPH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the RVPH dossier
Share

The RVPH intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.